Advertisement
Screener

Eastgate Biotech Corp Operating Cash Flow

Eastgate Biotech Corp Operating Cash Flow

Eastgate Biotech Corp reported Operating Cash Flow of -$1.58 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2019-03-04.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-03-04

  • Eastgate Biotech Corp net cash provided by (used in) operating activities for the quarter ending 2017-09-30 was -$1.33M, a 470.20% decline year-over-year.
  • Eastgate Biotech Corp net cash provided by (used in) operating activities for the quarter ending 2017-06-30 was -$131.03K.
  • Eastgate Biotech Corp net cash provided by (used in) operating activities for the quarter ending 2017-03-31 was -$121.48K.
  • Eastgate Biotech Corp net cash provided by (used in) operating activities for the quarter ending 2016-09-30 was $359.41K.
  • Eastgate Biotech Corp net cash provided by (used in) operating activities for fiscal 2013 was -$407.68K.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 142 monthNet Cash Provided by (Used in) Operating Activities 145 monthNet Cash Provided by (Used in) Operating Activities 148 monthNet Cash Provided by (Used in) Operating Activities 151 monthNet Cash Provided by (Used in) Operating Activities 154 monthNet Cash Provided by (Used in) Operating Activities 157 monthNet Cash Provided by (Used in) Operating Activities 160 monthNet Cash Provided by (Used in) Operating Activities 163 monthNet Cash Provided by (Used in) Operating Activities 166 monthNet Cash Provided by (Used in) Operating Activities 169 monthNet Cash Provided by (Used in) Operating Activities 172 monthNet Cash Provided by (Used in) Operating Activities 175 month
2017-09-30-$1.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-04
-$1.46M
derived: sum of 2 quarters · filed 2019-03-04
-$1.58M
10-Q · filed 2019-03-04
2017-06-30-$131.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-18
-$252.51K
10-Q · filed 2018-12-18
2017-03-31-$121.48K
10-Q · filed 2018-08-17
2016-09-30$359.41K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-04
-$112.00K
derived: sum of 2 quarters · filed 2019-03-04
-$215.51K
10-Q · filed 2019-03-04
2016-06-30-$471.42K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-18
-$574.92K
10-Q · filed 2018-12-18
2016-03-31-$103.50K
10-Q · filed 2018-08-17
2014-03-31-$412.90K
10-Q/A · filed 2014-05-19
-$588.78K
derived: sum of 2 quarters · filed 2014-05-19
-$746.36K
derived: sum of 3 quarters · filed 2014-05-19
-$745.80K
derived: sum of 4 quarters · filed 2014-05-19
-$821.08K
10-Q/A · filed 2014-05-19
2013-12-31-$175.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-02
-$333.46K
derived: sum of 2 quarters · filed 2014-04-02
-$332.90K
derived: sum of 3 quarters · filed 2014-04-02
-$407.68K
10-K · filed 2014-04-02
-$408.18K
10-K · filed 2014-04-02
2013-09-30-$157.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$157.02K
derived: sum of 2 quarters · filed 2013-11-13
-$231.79K
10-Q · filed 2013-11-13
-$232.29K
10-Q · filed 2013-11-13
2013-06-30$559.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14
-$74.21K
10-Q · filed 2013-08-14
-$74.71K
10-Q · filed 2013-08-14
2013-03-31-$74.77K
10-Q/A · filed 2014-05-19
-$75.27K
10-Q · filed 2013-05-07
2012-12-31-$500.00
10-K · filed 2013-04-16
2012-09-30-$500.00
10-Q · filed 2012-10-26
2012-06-30-$500.00
10-Q · filed 2012-08-20
2012-03-31-$500.00
10-Q · filed 2012-05-18
2011-12-31-$500.00
10-K · filed 2012-04-11
2011-09-30-$500.00
10-Q · filed 2011-11-14
2011-06-30-$500.00
10-Q/A · filed 2011-09-15